InDex Pharmaceuticals' Series B Round

InDex Pharmaceuticals raised a round of funding on February 26, 2014.

InDex Pharmaceuticals develops Kappaproct - a completely new type of drug that can help patients with severe ulcerative colitis back to a normal life. The results from an ongoing Phase III study are e…

Articles about InDex Pharmaceuticals' Series B Round: